Score computed from 28 publicly published third-party lab results. Every input links to its source below.
If you buy through our link or code we may earn a commission. This never affects scores or rank position.
Chimera Peptides is an unverified PeptideCensus listing. Listed website did not load or is parked at review; the operation's status is unclear. Its 28 published third-party results still appear on our compound boards, marked Unverified.
The Finnrick directory counts 28 published third-party results for Chimera Peptides, the latest dated 5 Oct 2026. It appears on 3 compound boards; its best scored placement is #4 on the Retatrutide board, scoring 91 from 16 tests.
Whichever seller you use, match the certificate to the lab's own records before trusting a vial: search its code in the Freedom Diagnostics lookup or check a Janoshik report with its key (how to verify a Janoshik report). A certificate covers one tested batch, so compare its batch number and date with the vial you receive.
| Compound | Rank | Score | Tests | Price/mg | Last test |
|---|---|---|---|---|---|
| Retatrutide | #4 | 91 | 16 | $1.00 | 5 Oct 2026 |
| KLOW | #11 | — | — | $0.28 | — |
| HGH | #13 | — | — | — | — |
Every leaderboard placement we track; each row links to the full board and its source record. Rows without scores are rating-level listings the published testing has not yet covered.
Get a heads-up when new tests publish for vendors we track.
Free, unsubscribe anytime. Address is used for the digest and nothing else; see the privacy policy.